News January 25, 2021 - Chimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares Read More January 8, 2021 - Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program Read More December 7, 2020 - Chimerix Announces FDA Acceptance of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox Read More May 21, 2020 - CalciMedica Announces that FDA Has Strongly Recommended Moving to a Blinded Placebo-controlled Trial with Auxora™ in Patients with Severe COVID-19 Pneumonia Read More January 8, 2020 - ViaCyte to Present at Biotech Showcase 2020 in San Francisco Read More November 7, 2019 - CalciMedica to Present Results of PD/PK Study in Acute Pancreatitis Patients for its CRAC Channel Inhibitor CM4620 at APA Annual Meeting Read More November 4, 2019 - ViaCyte to Present at ISSCR International Symposium: Stem Cell Biology to New Therapies Read More October 30, 2019 - The ViSi Mobile® Reusable cNIBP & SpO2 Thumb Sensor Read More October 30, 2019 - Henry Ford Hospital Physician Presents Results from the Initial Patient Study of CalciMedica’s CRAC Channel Inhibitor CM4620 in Acute Pancreatitis at ACEP Meeting Read More October 28, 2019 - New test improves diagnosis of a common genetic cause of autism Read More